Advanced Biomed (ADVB)

Profile

Full Name

Advanced Biomed Inc. Common Stock

Ticker Symbol

ADVB

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

March 6, 2025

Indexes

Not included

Website

http://www.advanbiomed.com

Employees

40

Key Details

Price

$1.81(-5.73%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.13(+25.44% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.81
ADVB price is $1.81

30-Day Relative Volume

0.87
ADVB 30-day relative volume is 0.87

Price Performance

Price Most recent change

-5.73%
ADVB price was down -5.73% on Apr 17, 2025

Price YTD change

-
ADVB price ytd change is unknown

Price 1-year change

-
ADVB price 1-year change is unknown

Price 3-year change

-
ADVB price 3-year change is unknown

Price Range

Price All-time high

$4.10
ADVB price is currently -55.85% below its historical high of $4.10

Price 3-year low

$1.47
ADVB price is currently +23.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$39.59M
ADVB market capitalization is $39.59 million

Market cap 3-year change

-
ADVB market capitalization 3-year change is unknown

Market cap All-time high

$87.50M
ADVB market capitalization is currently -54.75% below its historical high of $87.50 million

Market cap sector rank

34.65%
ADVB market capitalization is higher than 34.65% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
ADVB shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
ADVB shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
ADVB beta is 1.10

200-day SMA

$3.23
ADVB price is currently -43.90% below its 200-day simple moving average

50-day SMA

$3.23
ADVB price is currently -43.90% below its 50-day simple moving average

RSI

23.08
ADVB 14-day relative strength index is 23.08

Volume

0.87
ADVB 30-day relative volume is 0.87

ATR

$0.43
ADVB average true range is $0.43

10-day Historical Volatility

212.44%
ADVB 10-day historical volatility is 212.44%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ADVB annual revenue value is unknown

Revenue Analysts estimate

-
ADVB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ADVB annual revenue 1-year change is unknown

Revenue Sector rank

-
ADVB annual revenue is unknown

EPS

EPS

-$0.13
ADVB annual earnings per share is -$0.13

EPS Analysts estimate

-
ADVB annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+25.44%
ADVB annual earnings per share is up +25.44% year-on-year

EPS Sector rank

-
ADVB annual earnings per share is unknown

Profit

Gross profit

-
ADVB annual gross profit value is unknown

Gross margin

-
ADVB annual gross profit margin value is unknown

Operating profit

-$2.54M
ADVB annual operating income is -$2.54 million

Operating margin

-
ADVB annual operating profit margin value is unknown

Net income

-$2.78M
ADVB annual net profit is -$2.78 million

Net margin

-
ADVB annual net profit margin value is unknown

Expenses

Total expenses

$2.54M
ADVB annual total expenses is $2.54 million

Operating expenses

$2.54M
ADVB annual total operating expenses is $2.54 million

Cost of goods sold

-
ADVB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$1.26M
ADVB annual SGA is $1.26 million

Depreciation and amortization

$399.60K
ADVB annual depreciation & amortization is $399.60 thousand

Interest expense

-
ADVB annual interest expense value is unknown

Income tax

$0.00
ADVB annual income tax is $0.00

EBIT & EBITDA

EBIT

-$2.54M
ADVB annual earnings before interest & taxes is -$2.54 million

EBITDA

-$2.14M
ADVB annual EBITDA is -$2.14 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.46M
ADVB annual total assets is $4.46 million

Non current assets

$1.41M
ADVB annual long term assets is $1.41 million

Current assets

$3.05M
ADVB annual total current assets is $3.05 million

Cash and cash equivalents

$2.61M
ADVB annual cash & cash equivalents is $2.61 million

Accounts receivable

-
ADVB annual accounts receivable value is unknown

Inventory

-
ADVB annual inventory value is unknown

Liabilities

Total liabilities

$2.80M
ADVB annual total liabilities is $2.80 million

Long term liabilities

$64.50K
ADVB annual total long term liabilities is $64.50 thousand

Current liabilities

$2.73M
ADVB annual total current liabilities is $2.73 million

Accounts payable

$620.50K
ADVB annual accounts payable is $620.50 thousand

Debt

Total debt

$126.70K
ADVB annual total debt is $126.70 thousand

Total debt 1-year change

-46.18%
ADVB annual total debt is down -46.18% year-on-year

Long term debt

$64.50K
ADVB annual long term debt is $64.50 thousand

Short term debt

$62.20K
ADVB annual short term debt is $62.20 thousand

Equity & Capital

Shareholders equity

$1.66M
ADVB annual stockholders equity is $1.66 million

Book value

$1.66M
ADVB annual book value is $1.66 million

Retained earnings

-$15.97M
ADVB annual retained earnings is -$15.97 million

Working capital

$318.60K
ADVB annual working capital is $318.60 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.13M
ADVB annual cash flow from operations is -$2.13 million

Cash from operations 1-year change

+28.25%
ADVB annual cash flow from operations is up +28.25% year-on-year

Cash from investing

-$74.10K
ADVB annual cash flow from investing activities is -$74.10 thousand

Cash from investing 1-year change

+71.83%
ADVB annual cash flow from investing activities is up +71.83% year-on-year

Cash from financing

$1.87M
ADVB annual cash flow from financing activities is $1.87 million

Cash from financing 1-year change

+307.51%
ADVB annual cash flow from financing activities is up +307.51% year-on-year

CAPEX

CAPEX

-
ADVB annual capital expenditures value is unknown

CAPEX 1-year change

-
ADVB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$2.20M
ADVB annual free cash flow is -$2.20 million

Free cash flow 1-year change

+30.72%
ADVB annual free cash flow is up +30.72% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ADVB annual gross profit margin value is unknown

Operating margin

-
ADVB annual operating profit margin value is unknown

Net margin

-
ADVB annual net profit margin value is unknown

ROA & ROE

ROA

-62.38%
ADVB annual return on assets is -62.38%

ROE

-167.28%
ADVB annual return on equity is -167.28%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADVB price to earnings ratio value is unknown

PE ratio Sector rank

-
ADVB price to earnings ratio is unknown

PB Ratio

PB ratio

36.20
ADVB price to book ratio is 36.20

PB ratio Sector rank

98.19%
ADVB price to book ratio is higher than 98.19% of companies in Healthcare sector

PS Ratio

PS ratio

-
ADVB price to sales ratio value is unknown

PS ratio Sector rank

-
ADVB price to sales ratio is unknown

Enterprise value

Enterprise value

$37.07M
ADVB enterprise value is $37.07 million

Enterprise value Sector rank

37.85%
ADVB enterprise value is higher than 37.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-37.23
ADVB EV/EBITDA is -37.23

EV/EBITDA Sector rank

3.92%
ADVB EV/EBITDA is higher than 3.92% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.12
ADVB annual current ratio is 1.12

Quick ratio

-
ADVB annual quick ratio value is unknown

Leverage

Debt to equity

0.08
ADVB annual debt to equity ratio is 0.08

Interest coverage ratio

-
ADVB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ADVB piotroski f-score value is unknown

Altman Z-Score

-
ADVB altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Pheton Holdings Ltd Class A (PTHL)
CAMP logo
CAMP4 Therapeutics (CAMP)
RANI logo
Rani Therapeutics Holdings (RANI)
XLO logo
Xilio Therapeutics (XLO)
APLT logo
Applied Therapeutics (APLT)
AADI logo
Aadi Bioscience (AADI)
BLUE logo
bluebird bio (BLUE)
CNTB logo
Connect Biopharma Holdings Limited (CNTB)
HOWL logo
Werewolf Therapeutics (HOWL)
  • What is the ticker symbol for Advanced Biomed?
  • Does Advanced Biomed pay dividends?
  • What sector is Advanced Biomed in?
  • What industry is Advanced Biomed in?
  • What country is Advanced Biomed based in?
  • When did Advanced Biomed go public?
  • Is Advanced Biomed in the S&P 500?
  • Is Advanced Biomed in the NASDAQ 100?
  • Is Advanced Biomed in the Dow Jones?
  • When does Advanced Biomed report earnings?

What is the ticker symbol for Advanced Biomed?

The ticker symbol for Advanced Biomed is NASDAQ:ADVB

Does Advanced Biomed pay dividends?

No, Advanced Biomed does not pay dividends

What sector is Advanced Biomed in?

Advanced Biomed is in the Healthcare sector

What industry is Advanced Biomed in?

Advanced Biomed is in the Diagnostics & Research industry

What country is Advanced Biomed based in?

Advanced Biomed is headquartered in United States

When did Advanced Biomed go public?

Advanced Biomed's initial public offering (IPO) was on March 6, 2025

Is Advanced Biomed in the S&P 500?

No, Advanced Biomed is not included in the S&P 500 index

Is Advanced Biomed in the NASDAQ 100?

No, Advanced Biomed is not included in the NASDAQ 100 index

Is Advanced Biomed in the Dow Jones?

No, Advanced Biomed is not included in the Dow Jones index

When does Advanced Biomed report earnings?

The next expected earnings date for Advanced Biomed is May 30, 2025
On this page